IVERMECTIN LIST OF ARTICLES FOR NORMIES
Nobel Prize multi use for IVERMECTIN
https: (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/)// (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/)www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/ (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383101/)
IVERMECTIN for Cov2
https: (https://pubmed.ncbi.nlm.nih.gov/33278625/)// (https://pubmed.ncbi.nlm.nih.gov/33278625/)pubmed.ncbi.nlm.nih.gov/33278625/ (https://pubmed.ncbi.nlm.nih.gov/33278625/)
IVERMECTIN Science.org
https: (https://www.science.org/content/blog-post/s-up-ivermectin)// (https://www.science.org/content/blog-post/s-up-ivermectin)www.science.org/content/blog-post/s-up-ivermectin (https://www.science.org/content/blog-post/s-up-ivermectin)
REVISED IVERMECTIN LIST
IVM for Cov2 https://pubmed.ncbi.nlm.nih.gov/33278625
IVM Science.org https://www.science.org/content/blog-post/s-up-ivermectin
IVM World Use C19 https://ivmstatus.com
IVM Extremely safe https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740
IVM Works when distributed https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823
IVM works when administered
https://www.biznews.com/health/2021/07/29/ivermectin-treatment
IVM in India WHO white paper
https://www.financialexpress.com/lifestyle/health/covid-19-states-ignore-who-recommendation-on-ivermectin-heres-what-doctor-who-wrote-white-paper-on-the-drug-has-to-say/2231596
IVM anti viral action https://pubmed.ncbi.nlm.nih.gov/32462282
IVM stops viral replication https://www.sciencedaily.com/releases/2020/04/200403115115.htm
DHS reports IVM has ability to reduce viral shedding- BTFO https://www.dhs.gov/sites/default/files/publications/mql_pmc/articles/PMC8383101
FOR DOCTORS WHO AREN'T PRESCRIBING IVM
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness - PubMed
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf..
https://pubmed.ncbi.nlm.nih.gov/33278625
If anyone need ivermectin and fenbendazole make order from this website: https://www.genericcures.com/
Notice: Trying to access array offset on value of type bool in /home/admin/www/v2.anonup.com/themes/default/apps/timeline/post.phtml on line 1
Notice: Undefined index: owner in /home/admin/www/v2.anonup.com/themes/default/apps/timeline/post.phtml on line 36
Notice: Trying to access array offset on value of type null in /home/admin/www/v2.anonup.com/themes/default/apps/timeline/post.phtml on line 36
Notice: Undefined index: owner in /home/admin/www/v2.anonup.com/themes/default/apps/timeline/post.phtml on line 37
Notice: Trying to access array offset on value of type null in /home/admin/www/v2.anonup.com/themes/default/apps/timeline/post.phtml on line 37
Only followers of this user () can see their posts
REVISED IVERMECTIN LIST
IVM for Cov2 https://pubmed.ncbi.nlm.nih.gov/33278625
IVM Science.org https://www.science.org/content/blog-post/s-up-ivermectin
IVM World Use C19 https://ivmstatus.com
IVM Extremely safe https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3043740
IVM Works when distributed https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088823
IVM works when administered
https://www.biznews.com/health/2021/07/29/ivermectin-treatment
IVM in India WHO white paper
https://www.financialexpress.com/lifestyle/health/covid-19-states-ignore-who-recommendation-on-ivermectin-heres-what-doctor-who-wrote-white-paper-on-the-drug-has-to-say/2231596
IVM anti viral action https://pubmed.ncbi.nlm.nih.gov/32462282
IVM stops viral replication https://www.sciencedaily.com/releases/2020/04/200403115115.htm
DHS reports IVM has ability to reduce viral shedding- BTFO https://www.dhs.gov/sites/default/files/publications/mql_pmc/articles/PMC8383101
FOR DOCTORS WHO AREN'T PRESCRIBING IVM
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness - PubMed
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf..
https://pubmed.ncbi.nlm.nih.gov/33278625
